Continuous blood purification successfully treated severe cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy: A case report

Pediatr Blood Cancer. 2022 Aug;69(8):e29563. doi: 10.1002/pbc.29563. Epub 2022 Jan 19.

Authors

Feng Zhang¹, Xin-Lei Jia², Ying-Xi Zuo¹, Ai-Dong Lu¹, Peng-Fei Zhang², Lian Xue¹, Le-Ping Zhang¹

Affiliations

¹ Department of Pediatrics, Peking University People's Hospital, Beijing, China.
² Department of Pediatrics Intensive Care Unit, Beijing Children's Hospital, Capital Medical University, Beijing, China.

PMID: 35044056
DOI: 10.1002/pbc.29563

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Cell- and Tissue-Based Therapy
Cytokine Release Syndrome / etiology
Cytokine Release Syndrome / therapy
Humans
Immunotherapy, Adoptive / adverse effects
Neurotoxicity Syndromes* / etiology
Neurotoxicity Syndromes* / therapy
Receptors, Antigen, T-Cell
Receptors, Chimeric Antigen*

Substances

Receptors, Antigen, T-Cell
Receptors, Chimeric Antigen